Prader-Willi syndrome (PWS), an imprinted neurodevelopmental disorder characterized by metabolic, sleep and neuropsychiatric features, is caused by the loss of paternal SNORD116, containing only non-coding RNAs (ncRNAs). The primary SNORD116 transcript is processed into small nucleolar RNAs (snoRNAs), which localize to nucleoli, and their spliced host gene 116HG, which is retained at its site of transcription. While functional complementation of the SNORD116 ncRNAs is a desirable goal for treating PWS, the mechanistic requirements of SNORD116 RNA processing are poorly understood. Here we developed and tested a novel transgenic mouse which ubiquitously expresses Snord116 on both a wild-type and a Snord116 paternal deletion (Snord116 +/-) background. Interestingly, while the Snord116 transgene was ubiquitously expressed in multiple tissues, splicing of the transgene and production of snoRNAs was limited to brain tissues. Knockdown of Rbfox3, encoding neuron-specific splicing factor neuronal nuclei (NeuN) in Snord116 +/--derived neurons, reduced splicing of the transgene in neurons. RNA fluorescence in situ hybridization for 116HG revealed a single significantly larger signal in transgenic mice, demonstrating colocalization of transgenic and endogenous 116HG RNAs. Similarly, significantly increased snoRNA levels were detected in transgenic neuronal nucleoli, indicating that transgenic Snord116 snoRNAs were effectively processed and localized. In contrast, neither transgenic 116HG nor snoRNAs were detectable in either non-neuronal tissues or Snord116 +/-neurons. Together, these results demonstrate that exogenous expression and neuron-specific splicing of the Snord116 locus are insufficient to rescue the genetic deficiency of Snord116 paternal deletion. Elucidating the mechanisms regulating Snord116 processing and localization is essential to develop effective gene replacement therapies for PWS.
Introduction
Prader-Willi syndrome (PWS) is a neurodevelopmental disorder characterized by a broad range of symptoms including hypotonia and failure to thrive in infancy followed by the onset of hyperhagia, intellectual impairment, obsessive-compulsive tendencies and sleep abnormalities including shorter sleep duration and daytime sleepiness (1) . PWS is caused by paternal deficiency of the maternally imprinted 15q11-q13 locus, which encodes a long neuron-specific transcript (Fig. 1) . Expression of this locus originates at the PWS imprinting control region (IC) at the 5 end of SNRPN, extends through small nucleolar RNA (snoRNA) clusters SNORD116 (27 copies in human, >40 copies in mouse) and SNORD115 (47 copies in human, 37 copies in mouse) and terminates antisense to the maternally expressed UBE3A (UBE3A-ATS) (2) (3) (4) (5) . PWS is considered a contiguous gene disorder, as most patients carry large paternal deletions of this locus; however, analyses of PWS patients have revealed that small deletions of the SNORD116 cluster of snoRNAs are also sufficient to cause PWS (6) (7) (8) (9) . Snord116 is processed to form two non-coding RNAs (ncRNAs): Snord116 snoRNAs and the Snord116 host gene (116HG). Snord116 snoRNAs are intronically embedded within the noncoding Snord116 primary transcript, and although they currently have no known target sequence, they localize to the nucleolus in mature neurons (10) (11) (12) , detectable by RNA fluorescence in situ hybridization (FISH) (Fig. 1 ). It has also been proposed that these orphan snoRNAs are further processed, generating short fragments with non-canonical functions. Generation of these processed snoRNAs (psnoRNAs) is not well understood; however, it has been suggested that they may arise from the same host intron and depend on stability and protein interactions (13) . The nucleolar accumulation of Snord116 snoRNAs coincides with increased transcription of the locus, an increase in nucleolar size during early postnatal development and chromatin decondensation of the paternally expressed Snrpn-Ube3a allele, detected by DNA FISH (10) .
116HG is a long ncRNA (lncRNA) generated from the spliced exons of the Snord116 primary transcript. 116HG is retained within the nucleus and localizes to its paternally decondensed site of transcription, forming an 'RNA cloud', which associates with the Snord116 locus as well as other genes with epigenetic, metabolic and circadian functions regulating their expression in a time-of-day-dependent manner (11) . The 116HG cloud is significantly larger during light hours, corresponding to the downregulated expression of its gene targets during sleep (14) . Colocalized nuclear accumulation of the unspliced transcript and the spliced 116HG indicate that splicing occurs locally at the site of paternal expression (11) . Although splicing is required for 116HG formation and Snord116 snoRNA biogenesis, the mechanism of this process and its specificity for neurons is not well understood.
In an effort to determine phenotypes associated with genes within the PWS region, mouse models carrying deletions of nearly every paternally expressed gene in the human 15q11-q13 locus, either individually or as part of a large deletion, have been created and characterized (15) . Although some models exhibit a subset of PWS-like phenotypes, issues of lethality complicate phenotypic analyses of adult mice in some models, and no current mouse model of PWS exhibits consistency in the late onset obesity characteristic of PWS (15) (16) (17) . Currently, two mouse models (PWScr m+/p-and Snord116 +/-) carry deletions of the minimal Snord116 PWS critical region, and display postnatal growth deficiency characteristic of the early failure to thrive phenotype exhibited by PWS patients as well as some hyperphagic behavior (18, 19) . Activation of maternal Snord116 expression rescued the growth retardation and postnatal lethality phenotypes of the PWScr m+/p-small deletion model, supporting Snord116 as the PWS-critical region (20) . Although the snoRNAs have previously been the main focus of studies of the Snord116 locus, transgenic expression of a single copy of Snord116 snoRNA failed to rescue the phenotype of a Snrpn-Ube3a deletion mouse model, suggesting either that the Snord116 functional unit is not restricted solely to the snoRNAs or that multiple copies are required (19, 21) . Reintroduction of multiple copies of Snord116 snoRNAs expressed from the introns of another host gene failed to rescue the growth retardation phenotype of PWScr m+/p-mice, highlighting the functional significance of the 116HG (20) . Importantly, the regulation of circadian and metabolic gene expression by 116HG leads to dysregulated energy expenditure in mice deficient for paternal Snord116, suggesting that the lncRNA 116HG may play a role in the pathogenesis of PWS (14) . Finally, the introns of the Snord116 primary transcript may play a role in the regulation of Ube3a-ats progression by regulating chromatin compaction through the formation of R-loops (22) . These studies have illustrated the genetic complexity of the Snord116 locus and the potential functional capacity of multiple elements within this lncRNA. We designed a novel transgenic Snord116 mouse to characterize the processing and formation of these Snord116 RNA products, and define the mechanism regulating the brain specificity of these processes. By driving expression of Snord116 with a ubiquitous promoter, we investigated the requirements for Snord116 processing in multiple tissues and the potential of our transgene to compensate for the molecular deficits observed in Snord116 +/-mice. We show that Snord116 expression is not sufficient for the production of snoRNAs or the 116HG, and that the formation of these products is blocked at the level of tissuespecific splicing. Our data demonstrate a requirement for Rbfox3 in the neuron-specific splicing of Snord116, and an active paternal Snord116 allele in the localization of its processed RNA components, providing a better understanding of the requirements of Snord116 function in the development of potential future therapies for PWS.
Results

Transgenic Snord116 integrates into the genome and is expressed in many tissues
To reintroduce Snord116 in a highly expressed, ubiquitous manner to paternally Snord116-deficient mice, we engineered a novel 'complete' Snord116 transgene (Ctg) containing three complete Snord116 repeats under the control of a cytomegalovirus (CMV) promoter ( Fig. 2A) . Each unit of the Snord116 repeat contained an intronically encoded snoRNA flanked by 116HG exons, as organized in the genomic DNA. This construct was randomly inserted into the genome by pronuclear injection of fertilized oocytes to create a transgenic mouse carrying nine copies of the construct, representing 27 copies of the Snord116 repeat unit (Fig. 2B ). Mice were tested for transgene insertion by polymerase chain reaction (PCR) using primers specific to the transgene and inverse PCR was performed to identify the genomic location of the transgene integration at 7qE3, approximately 47 Mb from the endogenous Snord116 locus (Fig. 2C ). This falls outside of the 15q11-q13 imprinted locus and is therefore not expected to be co-regulated with endogenous Snord116. Transgenic Snord116 insertion overlaps with the poorly characterized gene Gm1966, which has been reported as both an unprocessed pseudogene as well as a protein-coding gene in different databases. Overall, no anatomical differences were observed between the brains of the wild-type and transgenic mice.
The Snord116 +/-PWS mouse model carries a ∼150 kb deletion of Snord116, representing the smallest region of overlap for human PWS deletions (6, 7, 9, 19) . Snord116 +/-mice recapitulate the neonatal failure to thrive exhibited by PWS patients and exhibit altered energy expenditure (14, 19 within neuronal nucleoli in any brain region or in non-neuronal tissues (Supplementary Material, Figs. S1 and 2). These results indicate that although transgenic Snord116 is able to contribute to endogenous snoRNAs, transcription of the primary transcript is not sufficient for the processing or localization of these RNAs in non-neuronal and Snord116-deficient neuronal tissues.
Neuron-specific splicing of transgenic Snord116 requires Rbfox3/NeuN
The discrepancy between expression of the primary transcript and production of functional snoRNA products from the Snord116 transgene led us to determine if splicing was the limiting factor in snoRNA processing. Using transgene-specific primers, we assessed splicing of transgenic Snord116 in several neuronal and non-neuronal tissues of Snord116 +/+ ;Ctg +/-and Snord116 +/-;Ctg +/-mice. Reverse transcription-PCR (RT-PCR) analysis demonstrated that splicing of transgenic Snord116 was restricted to neuronal tissues of both Snord116 +/+ ;Ctg +/-and Snord116 +/-;Ctg +/-mice (Fig. 4A ) even though primary transcripts were detected in multiple tissue types (Fig. 2D ). These results demonstrate that splicing may explain the tissue-specific differences between transcript expression and snoRNA localization, but not the deficiency of snoRNA processing in neurons of Snord116 +/-;Ctg +/-mice.
NeuN is commonly used in immunofluorescence staining as a neuron-specific marker, and has now been identified as the neuron-specific splicing factor, Rbfox3 (23) . To test the hypothesis that Rbfox3/NeuN regulates neuron-specific splicing of the Snord116 transgene, we performed an siRNA knockdown of Rbfox3 in neurons derived from Snord116 +/-;Ctg +/-neural progenitor cells (NPCs), reducing Rbfox3 expression to about 9% of levels detected in scramble siRNA-treated NPCs (Fig. 4B and Supplementary Material, Fig. S3 ). The expression of the transgenic Snord116 primary transcript was unaffected following Rbfox3 siRNA knockdown; however, the proportion of the primary transcript that was spliced (splicing /expression) was significantly reduced (Fig. 4B and Supplementary Material,  Fig. S3 ). To further examine a role for Rbfox3 in Snord116 splicing, we utilized a published dataset of RNA sequencing from Rbfox3 knockout mouse cerebral cortex (24) . Visualization of exon junctions within the Snord116 locus by sashimi plot using the Integrative Genomics Viewer (IGV) browser demonstrated that loss of Rbfox3 leads to pronounced dysregulation of exon splicing between Snord116 and Ube3a (Supplementary Material, Fig. S4 ). Together, these results demonstrate that Rbfox3 levels affect neuronal Snord116 splicing, and suggest that Rbfox3/NeuN is essential for the processing of intron-embedded snoRNAs.
The transgenic host gene 116HG RNA cloud localizes to the endogenous, but not the transgenic Snord116 locus, only in wild-type neurons
In addition to the nucleolar snoRNAs, the spliced exons of the Snord116 locus are retained as an RNA cloud that localizes to the site of transcription on the active paternal allele in wild-type neurons (22) (Fig. 1) . We therefore asked whether the transgenically-encoded 116HG localized to its own site of transcription using RNA FISH with a probe designed to detect the spliced junctions of both endogenous and transgenic 116HG. Similarly to the Snord116 snoRNA localization, 116HG FISH signals were observed as a single nuclear cloud in both Snord116 +/+ ;Ctg -/-and Snord116 +/+ ;Ctg +/-neurons, but not Snord116 +/-;Ctg -/-or Snord116 +/-;Ctg +/-neurons ( Fig. 5A and Figs. S5 and 6). In mice of two different ages (5.5 months and 1 year), the single 116HG RNA FISH signal was significantly larger in Snord116 +/+ ;Ctg +/-compared to Snord116 +/+ ;Ctg -/-neurons ( Fig. 5B) , suggesting that the transgenic spliced 116HG localized and contributed to the 116HG RNA cloud on the endogenous paternal allele. By DNA FISH, distinct nuclear locations of the three alleles (endogenous maternal and paternal, plus transgene) were observed (Fig. 5C ), demonstrating the absence of colocalization of the transgenic allele with the active paternal allele at the chromosomal level. In addition to our molecular analysis, we measured body weight for all genotypes from weaning until postnatal week 11. It has previously been reported that Snord116 +/-mice weigh significantly less than their WT littermates within this time frame (14, 19 To test the hypothesis that a second requirement for 116HG complementation is an active endogenous Snord116 locus, we utilized another transgenic mouse model, in which the maternal mouse PWS-IC has been replaced by the human PWS-IC (PWS-IC Hs /+) (25) . Because the human PWS-IC does not become imprinted in mice, the normally silent maternal allele undergoes chromatin decondensation and expresses Snrpn, snoRNAs and Ube3a-ats in neurons, similar to the paternal allele (Fig. 6B) 
Discussion
This study utilized a novel 27-copy Snord116 transgenic mouse to characterize the requirements for Snord116 processing and assess the molecular functional capacity of transgenic Snord116 in the absence of endogenous paternal expression. We demon- strated that transgenic Snord116 colocalizes with endogenous Snord116 snoRNAs and 116HG in the brain; however, transgenic Snord116 expression alone is not sufficient for the formation of functional RNAs from this locus, as they are not detected in tissues outside of the brain. Additionally, trafficking of transgenic RNAs is impaired in the absence of endogenous paternal Snord116; therefore, nuclear RNA cloud formation is observed only in the presence of endogenous Snord116 expression. Further, splicing of the Snord116 transgene was restricted to the brain, despite expression in many tissues. This process is partially blocked by the knockdown of Rbfox3 in NPC-derived neurons, suggesting a role for this neuron-specific splicing factor in the processing of Snord116. The introduction of transgenic Snord116 also fails to rescue the weight phenotype observed in Snord116 +/-mice. Splicing represents a critical step in the regulation of gene expression in all tissues; however, the brain exhibits the highest levels of tissue-specific alternative splicing (26) (27) (28) . Such tissue-specific splicing reflects the intricate cellular connections and functional diversity within the brain and exemplifies the complex expression and regulatory networks observed in the brain and during development. Brain-specific splicing factors provide an important mechanism for the co-and post-transcriptional regulation involved in processes such as neurogenesis and synapse formation through the spatiotemporal control of RNA expression, processing and localization (29, 30) . The Rbfox family of splicing factors is important in the regulation of brain development, with Rbfox3 expression uniquely confined to mature postmitotic neurons (31) . Neuronal co-expression and the presence of the (U)GCAUGbinding motif (32, 33) within the introns of the Snord116 transcript support the role for Rbfox3 in the processing of Snord116 in the brain. In addition, a recent study modeling the Rbfox3 regulatory network by crosslinking and immunoprecipitation followed by high-throughput sequencing identified significant peaks within the introns of Ipw, validating our Snord116-specific analysis of Rbfox3 activity (33) . Interestingly, RBFOX3 has been shown to be expressed at low levels in some immortalized human cell lines, where levels may be sufficient for the production of SNORD116 RNA products, or may be compensated for by the expression of other splicing factors including RBFOX1 or RBFOX2.
Ube3a, another gene within the 15q11-q13 locus, is paternally imprinted in neurons, in which the paternal expression of the Snrpn-Ube3a transcript extends through the anti-sense to Ube3a, blocking transcription of paternal Ube3a and leading to maternal-specific expression (34) (35) (36) . Interestingly, in Rbfox3/NeuN-negative cells of the suprachiasmatic nucleus (SCN), paternal Ube3a expression is observed (37). Due to its high level of GC skew, transcription through Snord116 results in the formation of R-loops, modulating the balance between chromatin state and transcription elongation. Stabilization of these R-loops by topotecan treatment stalls RNA polymerase II progression, blocking transcription through Ube3a-ats and resulting in biallelic Ube3a expression (22) . Conversely, a study of genome stability demonstrated the ability of the ASF/SF2 splicing factor to interact with R-loops, repressing their formation through interaction with the nascent RNA (38) . The Rbfox3-dependent silencing of paternal Ube3a in the SCN suggests that neuron-specific splicing of Snord116 by Rbfox3 may be important for maintaining the balance of R-loop formation, promoting transcription through Ube3a-ats and paternal imprinting of Ube3a in neurons.
It is important to note that the chromatin context of the transgene likely contributes to differences in the expression and processing of the primary transcript, which are lower than WT levels. It is therefore possible that the level of Snord116 expression produced by the transgene alone in Snord116 +/-; Ctg +/-mice may not be sufficient to compensate for the loss of endogenous Snord116. Despite low levels of transgenic primary transcript however, in the presence of splicing by Rbfox3 and the endogenous chromatin for localization, this transgenic primary transcript contributes significantly to the formation of mature RNA products in the brain. This indicates a potential multi-level deficit in the production of functional RNAs from transgenic Snord116 in Snord116 +/-;Ctg +/-neurons and in all non-neuronal tissues. Paternal Snord116 is GC skewed, resulting in R-loop formation, histone displacement and chromatin decondensation upon neuronal transcription and the specific localization of the 116HG to its site of transcription at the decondensed paternal allele suggests a chromatin-state-dependent accumulation of 116HG (22) . The formation of two 116HG RNA clouds in PWS-IC Hs /+ neuronal nuclei demonstrates the requirement for a decondensed endogenous allele for the localization of Snord116, suggesting that chromatin decondensation may mediate RNA-DNA interactions necessary to anchor the 116HG to its proper subnuclear domain. The lack of phenotypic rescue by the Snord116 transgene is in agreement with the lack of rescue at the molecular level; however, the negative combinatorial effect of endogenous and transgenic Snord116 may reflect the aberrant expression of Snord116 in tissues outside of the brain important for metabolism. Further study of the mechanisms of Snord116 localization would benefit our understanding of the requirements for Snord116 function and enable the development of more effective therapies in the future.
Materials and Methods
Mouse husbandry
C57BL/6J (WT) and B6(Cg)-Snord116tm1.1Uta/J (Snord116 +/-) mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA 
Snord116 +/-;Ctg +/-(Ctg/Prad). All mice used for this study were male and tissues were collected during light hours (ZT0-ZT12).
RNA FISH and DNA FISH
Snord116 BAC RP23-358G20 was ordered from BACPAC Resources (Children's Hospital Oakland Research Institute). Nick translation of DIG-labeled probes and DNA FISH was performed as described previously (10) . RNA FISH was performed as described previously (10) . 116HG probes = AATGCAACCCTTTTAACTCAG (Exiqon), pooled probes (Agilent).
snoRNA probe = TTCCGATGAGAGTGGCGGTACAGA (Exiqon).
Microscopy
Slides were imaged on an Axioplan 2 fluorescence microscope (Carl Zeiss, Inc., NY, USA), equipped with a Qimaging Retiga EXi high-speed uncooled digital camera and analyzed using iVision Software (BioVision Technologies, Inc., Exton, PA, USA). Images were captured using a 100× oil objective and 1× camera zoom. 116HG RNA cloud measurements were taken as two perpendicular cross sections through the center of the RNA cloud and averaged for RNA cloud size. snoRNA intensity was measured as the sum of the intensity of each pixel divided by the area measured. All measurements were converted from pixel counts to microns according to objective and zoom (1px = 0.069 μm). All measurements and spot counting were blinded to minimize bias.
Reverse transcriptase PCR (RT-PCR) and quantitative RT-PCR (qRT-PCR)
RNA was isolated with the RNeasy mini kit (Qiagen, Hilden, Germany) and complementary DNA (cDNA) was synthesized using the QuantiTect Reverse Transcription Kit (Qiagen). For qRT-PCR, cDNA was amplified using the SensiFAST SYBR Lo-Rox Kit (Bioline, London, UK). Custom primers were designed using Primer3 software.
Ctg expression (transgene specific):
F -taagcagagctggtttagtgaacc; R -aacagttcgatggagactcagttgg
Ctg splicing (transgene specific):
F -cctgagttaaaaggcggccg; R -gccatttcctctgcatgttt
Rbfox3 expression:
F -aattttcccgaattgcccgaac; R -atgaagcagcacagacagacaa
Snord116 expression (endogenous + transgenic):
F -atgcaggctgctggtagagt; R -cctccaaggcttagctcctt
Gapdh expression (39):
F -caaggagtaagaaaccctggacc; R -cgagttgggatagggcctct
NPC and neuron culture
Embryos were dissected and cortices removed at E15. NPCs were isolated as described previously (40) and cultured in NEP Complete media supplemented with GlutaMAX. To differentiate, neurospheres were dissociated with Accutase (Invitrogen) and filtered for a single-cell suspension. Plates were coated with Poly-D-lysine (Sigma, St. Louis, MO, USA) and laminin (Invitrogen) and media was changed to Neurobasal with retinoic acid and brainderived neurotrophic factor.
siRNA knockdown
Rbfox3 was knocked down using a pool of three Stealth RNAi siRNA or a negative control siRNA at 55 pmol RNAi per 60 mm dish (Life Technologies, Carlsbad, CA, USA). Neurons were differentiated for 7 days followed by 3 days of knockdown. RNA was then extracted and evaluated for knockdown efficiency by qRT-PCR and expression/splicing by RT-PCR.
Inverse PCR
Genomic DNA was isolated from tail clipping using the Gentra Puregene Kit (Qiagen). DNA was digested with DpnII and circularized by T4 ligation (Promega, Madison, WI, USA). Primers were designed to the known transgene sequence to amplify the unknown flanking genomic region. The PCR product was gel purified and sequenced by Sanger sequencing. Sequences flanking the DpnII restriction site were mapped to the transgene and the genome flanking.
Inverse PCR primers:
F -gatttccaagtctccaccccat; R -ggctatgaactaatgaccccgt
RNA-sequencing analysis
SRA files were downloaded from GEO (GSE84786) (24) and converted to fastq files using fastq-dump, splitting files for paired-end reads. Reads were trimmed for adapters and quality using the following parameters: ILLUMINACLIP:TruSeq3-PE.fa:2:30:10:8:T LEADING:15 TRAILING:15 SLIDINGWINDOW:
15. An insert size of 200 bp was used based on Picard metrics and reads were aligned to mm10 using TopHat2. Bam index files were built using Picard Tools and stranded bed files were created and used to create bedGraph and bigwig files for visualization as custom tracks on the UCSC genome browser. Raw bam files were loaded into the IGV browser to create sashimi plots (MISO framework) (41, 42) .
Supplementary Material
Supplementary Material is available at HMG online.
